We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.5B
1-Year Est. Return
11.68%
This Fund
S&P 500
This Quarter
Est. Return
+0.28%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$659M
AUM Growth
–
Cap. Flow
+$668M
Cap. Flow
% of AUM
101.44%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
251
New
251
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$22.6M |
| 2 |
ExxonMobil
XOM
|
+$19.3M |
| 3 |
Johnson & Johnson
JNJ
|
+$16.5M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$16.4M |
| 5 |
SRCL
Stericycle Inc
SRCL
|
+$13.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.36% |
| 2 | Technology | 12.4% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Staples | 11.28% |
| 5 | Energy | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aflac
AFL
$65B
| $7.24M | 1.1% |
+249,114
| New | +$6.76M |
|
27
IBM
IBM
$214B
| $7M | 1.06% |
+38,301
| New | +$7.46M |
|
28
Apple
AAPL
$4.49T
| $6.91M | 1.05% |
+487,816
| New | +$7.5M |
|
|
PX
29
DELISTED
Praxair Inc
PX
| $6.82M | 1.04% |
+59,237
| New | +$6.75M |
|
30
Rockwell Automation
ROK
$53.4B
| $6.82M | 1.04% |
+82,048
| New | +$7.09M |
|
31
Cisco
CSCO
$453B
| $6.12M | 0.93% |
+251,664
| New | +$5.66M |
|
32
Philip Morris
PM
$294B
| $6.12M | 0.93% |
+70,606
| New | +$6.56M |
|
33
Vanguard FTSE All-World ex-US ETF
VEU
$66.5B
| $5.58M | 0.85% |
+126,221
| New | +$5.9M |
|
34
Nike
NKE
$63.2B
| $5.54M | 0.84% |
+174,046
| New | +$5.41M |
|
35
Berkshire Hathaway Class B
BRK.B
$1.12T
| $5.41M | 0.82% |
+48,324
| New | +$5.32M |
|
|
DD
36
DELISTED
Du Pont De Nemours E I
DD
| $5.39M | 0.82% |
+108,075
| New | +$5.46M |
|
37
Parker-Hannifin
PH
$123B
| $5.36M | 0.81% |
+56,204
| New | +$5.27M |
|
38
Golar LNG
GLNG
$4.91B
| $5.2M | 0.79% |
+162,945
| New | +$5.6M |
|
39
Chevron
CVX
$386B
| $5.15M | 0.78% |
+43,509
| New | +$5.26M |
|
40
Teva Pharmaceuticals
TEVA
$40.6B
| $5.02M | 0.76% |
+128,127
| New | +$4.99M |
|
41
Ecolab
ECL
$78.5B
| $4.99M | 0.76% |
+58,570
| New | +$4.94M |
|
42
Merck
MRK
$318B
| $4.87M | 0.74% |
+109,903
| New | +$4.91M |
|
43
3M
MMM
$92B
| $4.85M | 0.74% |
+53,031
| New | +$4.81M |
|
44
Stryker
SYK
$128B
| $4.76M | 0.72% |
+73,580
| New | +$4.88M |
|
45
Dollar Tree
DLTR
$25.1B
| $4.62M | 0.7% |
+90,872
| New | +$4.43M |
|
46
Danaher
DHR
$140B
| $4.45M | 0.68% |
+104,653
| New | +$4.33M |
|
47
NextEra Energy
NEE
$180B
| $4.44M | 0.67% |
+217,900
| New | +$4.32M |
|
48
Coca-Cola
KO
$377B
| $4.33M | 0.66% |
+107,953
| New | +$4.47M |
|
49
AbbVie
ABBV
$440B
| $4.29M | 0.65% |
+103,730
| New | +$4.54M |
|
50
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $4.15M | 0.63% |
+116,486
| New | +$4.35M |
|
Similar funds
CP
JFGLC
AAM
TP
SCM
FMI
NSGL
RCW
Boston Family Office's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Boston Family Office, which disclosed 251 positions worth $659M. Its ten largest holdings account for 22% of the portfolio.
Its largest position is Vanguard FTSE Emerging Markets ETF: 539,199 shares worth $20.9M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, followed by Technology and Industrials.
- Boston Family Office's largest Q2 2013 buy was Vanguard FTSE Emerging Markets ETF: 539,199 shares worth $20.9M.
- Boston Family Office's ten largest holdings make up 22% of its $659M portfolio in Q2 2013.
- Boston Family Office disclosed 251 positions in Q2 2013, its first 13F filing on record.
Based on Boston Family Office's 13F filing for Q2 2013, filed 25 Jul 2013.